| Source NDC Code |
|
Target HCPCS Code |
51759-0208-13
EPYSQLI 300 MG/30 ML VIAL
|
⇄
|
Q5151
Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
|
| Detail Information |
| Relationship Start Date |
10/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
51759-0208-13
Epysqli
|
⇄
|
Q5151
Inj, eculizumab-aagh, 2 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|